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Summary: GC×GC-(HR)-TOFMS is a powerful hyphenated technique for the consideration of (semi)-
volatile analytes. It is used for the search of biomarkers of illness for better understanding of 
metabolic processes in medical applications. This includes profiling VOC signatures in breath, in the 
headspace of bio-fluids and cultured cell media, or performing direct metabolite screening in fluids. 
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Introduction   
Comprehensive two-dimensional gas chromatography (GC×GC), especially when coupled to time-of-
flight mass spectrometry (TOFMS), has come a long way since the original report on the technique in 
early 1990’s. Several robust modulation devices (cryogenic modulators, flow modulators, solid state 
modulators, …) are now available and cover most fields of applications.  Current GC×GC-TOFMS 
instruments allow to separate thousands of signals for semi-routine analyses of large sets of samples. 
Data processing requires complex dedicated procedures to properly extract the relevant information 
from the tremendous quantity of multidimensional data, especially when high resolution (HR)TOFMS 
is used. 
Amongst the numerous fields of application of GC×GC-TOFMS, medical applications are of high 
interest as they ultimately can play a role in public health at a large scale. Such applications include 
search for biomarkers of illness and understanding of metabolic processes. These type of studies 
usually require profiling volatile organic compounds (VOCs) present in breath; measuring headspace 
VOC signatures from blood, urine, feces, and cultured cell media; or performing metabolite screening 
on plasma samples… 
For each of these, it is important to develop and optimize proper sampling procedures often based on 
solid-phase microextraction (SPME) or thermal desorption (TD). The implementation of robust 
chromatographic methods is also crucial to ensure that high quality signals are produced prior to any 
data processing. Then, the most important aspects to be considered are data alignment, data reduction, 
(un)supervised statistics, and visualization of results. Several data mining approaches and statistical 
tools (Fisher ratio, PCA, PLS, clustering, machine learning…) have been implemented to digest the 
large amount of data generated. This will be illustrated through recent achievements in the medical 
field in terms of volatilomics and metabolomics. 
 
Methods 
We developed and implemented several GC×GC-HRTOFMS methods for both target and untarget 
metabolomics as well as volatile profiling of human samples such as exhaled breath, serum, and 
bronchoalveolar lavage fluids (BALF) under strict QA/QC guidelines. We developed a robust data 
processing approach based on templates relying on GC and MS quality features, and multiple 
(un)supervised statistical techniques. 
 
Results 
Breath analyses were carried out in several volatilomic studies on lung cancer and asthma. In both 
cases, GC×GC-HRTOFMS permitted to isolate putative biomarkers of disease that were selected 
during model creation of test sets further applied on training set for testing of the robustness. In asthma 
phenotype studies over more than 150 patients, sets of markers were validated for the differentiation of 
phenotypes, as illustrated in ROC curves displayed in Fig. 1. 
                   
Fig. 1 : ROC curves for differentiation of neutrophilic and Paucigranulocytic (left) and eosinophilic and 
Paucigranulocytic (right) phenotypes based on a set of respectively 2 and 3 selected markers (exact identities 
known but not under appropriate protection for diffusion). 
 
The use of Fisher ratio (FR) calculation using a statistical cut off value or classical Random decision 
forests allowed to extract analytes of interest from the large matrices of features produced by GC×GC-
HRTOFMS. The use of MS libraries, the high mass accuracy (<1ppm) of the MS analyzers, and the 
linear retention indices (LRIs) allowed to known the exact identities of most isolated markers. PCA 
and HCA were used for data reduction and visualization purposes. Fig. 2 illustrates the PCA and HCA 
for a study on inflammatory bowel disease (Crohn’s disease) for a class of blood samples (30 µL) 
from highly inflamed patients versus a class of healthy controls.  
 
             
Fig. 2 : PCA score plot (left) and HCA plot (right) for the separation of Crohn’s disease patients from controls 
based on a set of 14 putative biomarkers isolated from blood samples (exact identities known but not under 
appropriate protection for diffusion). 
 
System stability was ensured based on the monitoring of quality control charts over time for retention 
time deviation in both first and second dimension, as well as instrumental relative response against 
selected standards. Quality control samples and NIST SRM were used and LOESS regression used to 
ensure reliability of the data.  
 
Conclusions 
GC×GC-HRTOFMS and appropriate data reduction/treatment is a valuable approach for serum 
metabolomics and volatilomics in the context of medical applications. High levels of QA/QC are 
requested to offer the requested level of robustness and possible future clinical use.  
 
